• 1
    Roberts JM, Pearson G, Cutler J, Lindheimer MD. Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertens Pregnancy 2003; 22: 109127.
  • 2
    Tan TY, Yeo GS. Intrauterine growth restriction. Curr Opin Obstet Gynecol 2005; 17: 135142.
  • 3
    Schlembach D. Pre-eclampsia—still a disease of theories. Fukushima J Med Sci 2003; 49: 69115.
  • 4
    Wollmann HA. Intrauterine growth restriction: definition and etiology. Horm Res 1998; 49 (Suppl 2): 16.
  • 5
    Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005; 308: 15921594.
  • 6
    Roberts JM, Gammill HS. Preeclampsia: recent insights. Hypertension 2005; 46: 12431249.
  • 7
    Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, Epstein FH, Sukhatme VP, Karumanchi SA. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111: 649658.
  • 8
    Schlembach D, Beinder E. Angiogenic factors in preeclampsia. J Soc Gynecol Invest 2003; 10: 316A.
  • 9
    Tsatsaris V, Goffin F, Munaut C, Brichant JF, Pignon MR, Noel A, Schaaps JP, Cabrol D, Frankenne F, Foidart JM. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: pathophysiological consequences. J Clin Endocrinol Metab 2003; 88: 55555563.
  • 10
    Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, Sibai BM, Sukhatme VP, Karumanchi SA. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350: 672683.
  • 11
    Bersinger NA, Odegard RA. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for gestational age pregnancies. Acta Obstet Gynecol Scand 2004; 83: 3745.
  • 12
    He Y, Smith SK, Day KA, Clark DE, Licence DR, Charnock-Jones DS. Alternative splicing of vascular endothelial growth factor (VEGF)-R1 (FLT-1) pre-mRNA is important for the regulation of VEGF activity. Mol Endocrinol 1999; 13: 537545.
  • 13
    Helske S, Vuorela P, Carpen O, Hornig C, Weich H, Halmesmaki E. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod 2001; 7: 205210.
  • 14
    Staff AC, Braekke K, Harsem NK, Lyberg T, Holthe MR. Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol 2005; 122: 3339.
  • 15
    Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Goncalves LF, Gomez R, Edwin S. Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia: Young Investigator Award. Am J Obstet Gynecol 2004; 190: 15411547.
  • 16
    Shibata E, Rajakumar A, Powers RW, Larkin RW, Gilmour C, Bodnar LM, Crombleholme WR, Ness RB, Roberts JM, Hubel CA. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational-age neonates: relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005; 90: 48954903.
  • 17
    Stepan H, Geide A, Faber R. Soluble fms-like tyrosine kinase 1. N Engl J Med 2004; 351: 22412242.
  • 18
    Ebos JM, Bocci G, Man S, Thorpe PE, Hicklin DJ, Zhou D, Jia X, Kerbel RS. A naturally occurring soluble form of vascular endothelial growth factor receptor 2 detected in mouse and human plasma. Mol Cancer Res 2004; 2: 315326.
  • 19
    Masuyama H, Suwaki N, Nakatsukasa H, Masumoto A, Tateishi Y, Hiramatrsu Y. Circulating angiogenic factors in preeclampsia, gestational proteinuria, and preeclampsia superimposed on chronic glomerulonephritis. Am J Obstet Gynecol 2006; 194: 551556.
  • 20
    Bikfalvi A, Klein S, Pintucci G, Rifkin DB. Biological roles of fibroblast growth factor-2. Endocr Rev 1997; 18: 2645.
  • 21
    Hamai Y, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y. Evidence for basic fibroblast growth factor as a crucial angiogenic growth factor, released from human trophoblasts during early gestation. Placenta 1998; 19: 149155.
  • 22
    Hill DJ, Tevaarwerk GJ, Arany E, Kilkenny D, Gregory M, Langford KS, Miell J. Fibroblast growth factor-2 (FGF-2) is present in maternal and cord serum, and in the mother is associated with a binding protein immunologically related to the FGF receptor-1. J Clin Endocrinol Metab 1995; 80: 18221831.
  • 23
    Hohlagschwandtner M, Knofler M, Ploner M, Zeisler H, Joura EA, Husslein P. Basic fibroblast growth factor and hypertensive disorders in pregnancy. Hypertens Pregnancy 2002; 21: 235241.
  • 24
    Harman CR, Baschat AA. Comprehensive assessment of fetal wellbeing: which Doppler tests should be performed? Curr Opin Obstet Gynecol 2003; 15: 147157.
  • 25
    Hadlock FP, Harrist RB, Sharman RS, Deter RL, Park SK. Estimation of fetal weight with the use of head, body, and femur measurements—a prospective study. Am J Obstet Gynecol 1985; 151: 333337.
  • 26
    Kupferminc MJ, Daniel Y, Englender T, Baram A, Many A, Jaffa AJ, Gull I, Lessing JB. Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol 1997; 38: 302306.
  • 27
    McNeil PL, Muthukrishan L, Warder E, D'Amore PA. Growth factors are released by mechanically wounded endothelial cells. J Cell Biol 1989; 109: 811822.
  • 28
    Ferrazzi E, Bulfamante G, Mezzopane R, Barbera A, Ghidini A, Pardi G. Uterine Doppler velocimetry and placental hypoxic-ischemic lesion in pregnancies with fetal intrauterine growth restriction. Placenta 1999; 20: 389394.
  • 29
    Barleon B, Hauser S, Schöllmann C, Weindel K, Marme D, Yayon A, Weich HA. Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells. J Cell Biochem 1994; 54: 5666.
  • 30
    Vetter K, Gonser M, Gasiorek-Wiens A. Dopplersonographie in der Schwangerschaft. In Ultraschall in Gynäkologie und Geburtshilfe, SohnC, HolzgreveW (eds). Georg Thieme Verlag: Stuttgart/New York, 1995; 522.